Reddy's (Brazil, Turkey, Canada using smaller markets as supply chain rehearsals for the 2032 US launch)
Do not use this medicine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, or tranylcypromine, or if you have received a methylene blue injection
Early side effects like mild nausea, constipation, or decreased appetite for favorite foods typically peak at 12 weeks and gradually subside by week 46 as your body adjusts
Approval Based on Comprehensive Data: Oral semaglutides approval is based on comprehensive data from clinical trials, laboratory studies, and post-market reviews, ensuring it meets FDA standards for safety and efficacy for weight loss